8-K
filed March 8, 2024, 6:59 PM ET
ticker IMUX
CIK 0001280776
other material
confidence high
sentiment neutral
materiality 0.50
Immunic stockholders approve increase in authorized shares from 130M to 500M at special meeting
IMMUNIC, INC.
- Shareholders approved amendment to certificate of incorporation to increase authorized common stock from 130M to 500M shares.
- Approved amendment to 2021 ESPP increasing reserved shares by 1M to 1.2M shares.
- Approved amendment to 2019 Omnibus Equity Plan increasing authorized shares by 9.1M to 19.4M shares.
- Approved repricing of stock options with exercise price above $3.00 to greater of $1.72 or 110% of future closing price.
Key facts
Extracted from this filing and checked against the source text.
Governance Changes
SEC 8-K Item 5.03/5.05/5.06
confidence 0.9
IMMUNIC, INC.: Increased authorized shares of common stock from 130,000,000 to 500,000,000 (effective 2024-03-06).
- Change
- charter amendment
- Effective
- 2024-03-06
Exact text from the filing
the stockholders of Immunic, Inc. (the "Company") approved an amendment to Article Four, Part A of the Company's Amended and Restated Certificate of Incorporation to increase the total number of authorized shares of common stock, $0.0001 par value per share (the "Common Stock"), from 130,000,000 shares of Common Stock to 500,000,000 shares of Common Stock (the "Amendment"). The Amendment did not change the number of shares of preferred stock that the Company is authorized to issue. On March 5, 2024, the Company filed the Amendment with the Secretary of State of the State of Delaware, which became effective on March 6, 2024.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
IMMUNIC, INC. shareholders approved Amendment to the Amended and Restated 2021 Employee Stock Purchase Plan to increase shares reserved by 1,000,000 to a total of 1,200,000. at the 2024-03-04 meeting.
- Proposal
- equity plan
- Outcome
- passed
- Meeting
- 2024-03-04
Exact text from the filing
Proposal 2: Approval of an Amendment to the Company’s Amended and Restated 2021 Employee Stock Purchase Plan FOR AGAINST ABSTAIN BROKER NON-VOTES 59,279,567 757,471 56,090 0
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
IMMUNIC, INC. shareholders approved Amendment to the 2019 Omnibus Equity Incentive Plan, as amended, to increase shares authorized by 9,100,000 to a total of 19,448,871. at the 2024-03-04 meeting.
- Proposal
- equity plan
- Outcome
- passed
- Meeting
- 2024-03-04
Exact text from the filing
Proposal 3: Approval of an Amendment to the Company’s 2019 Omnibus Equity Incentive Plan, as Amended FOR AGAINST ABSTAIN BROKER NON-VOTES 52,994,383 6,866,888 231,857 0
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
IMMUNIC, INC. shareholders approved Amendment to the Amended and Restated Certificate of Incorporation to increase authorized shares of Common Stock from 130,000,000 to 500,000,000. at the 2024-03-04 meeting.
- Proposal
- charter amendment
- Outcome
- passed
- Meeting
- 2024-03-04
Exact text from the filing
Proposal 1: Approval of an Amendment to the Company’s Amended and Restated Certificate of Incorporation FOR AGAINST ABSTAIN BROKER NON-VOTES 59,487,494 397,612 208,022 0
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
IMMUNIC, INC. shareholders approved Approval of the repricing of certain outstanding stock options having exercise price above $3.00 per share to the greater of $1.72 and 110% of closing price on a future repricing date. at the 2024-03-04 meeting.
- Proposal
- equity plan
- Outcome
- passed
- Meeting
- 2024-03-04
Exact text from the filing
Proposal 4: Approval of the Repricing of Certain Outstanding Stock Options FOR AGAINST ABSTAIN BROKER NON-VOTES 48,849,469 11,026,993 216,666 0
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.